跳至主要内容
临床试验/JPRN-jRCTs041180026
JPRN-jRCTs041180026已完成4 期

The efficacy of elobixibat as bowel cleansing agent for bowel preparation before colonoscopy, A prospective, randomized and multi-center study - Elobixibat study

Yamaguchi Daisuke0 个研究点目标入组 210 人开始时间: 2019年1月16日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
210

研究概览

简要总结

The combination of elobixibat and 1-L PEG-Asc can be considered an alternative bowel preparation for colonoscopy considering the equivalent bowel cleansing effect and less frequent sleep disturbance.

研究设计

研究类型
Interventional

入排标准

年龄范围
20age 至 none(—)
性别
All

入选标准

  • adults at least 20 years of age

排除标准

  • If they had any of the following conditions: ileus, suspected bowel obstruction or toxic megacolon; prior abdominal or pelvic surgery; inflammatory bowel disease; malignancy; severe cardiac disease (heart failure beyond NYHA Class III); chronic obstructive pulmonary disease, interstitial lung disease or uncontrolled asthma; renal failure and on dialysis, decompensated liver cirrhosis; coagulopathy or other hematologic disease with bleeding tendency; dementia or other cognitive disorders; or hypersensitivity to elobixibat. And if they were pregnant or breastfeeding.

研究者

发起方
Yamaguchi Daisuke

相似试验